Clinical trial
Neural Autoantibody Prevalence in Patients With New-onset Focal Seizures of Unknown Etiology and a Predictive Scoring Scale
NCT06388161 is registered in ClinicalTrials.gov with Shen Chun-Hong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neural Autoantibody Prevalence in Patients With New-onset Focal Seizures of Unknown Etiology and a Predictive Scoring Scale
- Lead sponsor
- Shen Chun-Hong
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2023
- Completion date
- December 31, 2030
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
encephalitis autoimmune, epilepsy